EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Systemic lupus erythematosus and antiphospholipid syndrome after COVID-19 vaccination. A case report

Sebastian Molina-Rios iD, Rigoberto Rojas-Martinez, Gloria Marcela Estévez-Ramirez, Yimy Francisco Medina

Modern Rheumatology Case Reports · 03.01.2023 · 7 (1) · 43-46

DOI: 10.1093/mrcr/rxac018 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Modern Rheumatology Case Reports, online erschienen am 04.03.2022. Verfasst von Sebastian Molina-Rios und 3 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Unit, Department of Internal Medicine, School of Medicine, Universidad Nacional de Colombia, Carrera 30 No. 45-03, Bogotá DC 111321, Col…. Hauptthemen laut MEDLINE: Antiphospholipid Syndrome, COVID-19, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coronavirus disease 2019 (COVID-19) vaccines have some adverse effects, mostly mild. However, by presenting an immunological challenge to the individual, they could infrequently trigger immune-mediated diseases (IMDs). We report the case of a 42-year-old woman, with no previous medical history, who received the first dose of vaccine against COVID-19 and developed inflammatory arthralgias, associated with sudden-onset dyspnoea and hypoxemia. Pulmonary thromboembolism was documented, and the diagnosis of systemic lupus erythematosus (SLE) and secondary antiphospholipid syndrome (APS) was suspected. Autoantibodies were measured confirming this suspicion. After a few days, she presented a massive pericardial effusion with cardiac tamponade that required surgical management. Treatment with azathioprine, hydroxychloroquine, corticosteroids, and anticoagulation was indicated with improvement of all her symptoms. There is controversy regarding the potential of COVID-19 vaccines to induce autoimmunity. Studies addressing the safety of using these vaccines have reported the occurrence of mild local and systemic reactions, most frequently in young adults. So far, there are few reports of patients who have developed autoimmune or autoinflammatory diseases after getting vaccinated with any of the COVID-19 vaccines. To the best of our knowledge, to date, this is one of the first cases of new-onset SLE and secondary APS after COVID-19 vaccination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiphospholipid SyndromeCOVID-19Lupus Erythematosus, SystemicFemaleYoung AdultHumansAdultCOVID-19 VaccinesVaccination

Stichwörter der Autor:innen

COVID-19SARS-CoV-2cardiac tamponadesystemic lupus erythematosusvaccines

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Rheumatology Unit, Department of Internal Medicine, School of Medicine, Universidad Nacional de Colombia, Carrera 30 No. 45-03, Bogotá DC 111321, Colombia.
  • Rheumatology Unit, Department of Internal Medicina, Hospital Universitario Nacional de Colombia, Calle 44 No. 59-75, Bogotá DC 111321, Colombia.

ORCID-Profile: Sebastian Molina-Rios

Zitieren

APA

Molina-Rios, S., Rojas-Martinez, R., Estévez-Ramirez, G. M., & Medina, Y. F. (2023). Systemic lupus erythematosus and antiphospholipid syndrome after COVID-19 vaccination. A case report. Modern Rheumatology Case Reports, 7(1), 43-46. https://doi.org/10.1093/mrcr/rxac018

Vancouver

Molina-Rios S, Rojas-Martinez R, Estévez-Ramirez GM, Medina YF. Systemic lupus erythematosus and antiphospholipid syndrome after COVID-19 vaccination. A case report. Modern Rheumatology Case Reports. 2023;7(1):43-46. doi:10.1093/mrcr/rxac018

BibTeX
@article{MolinaRios2023,
  author = {Molina-Rios, Sebastian and Rojas-Martinez, Rigoberto and Estévez-Ramirez, Gloria Marcela and Medina, Yimy Francisco},
  title = {Systemic lupus erythematosus and antiphospholipid syndrome after COVID-19 vaccination. A case report},
  journal = {Modern Rheumatology Case Reports},
  year = {2023},
  volume = {7},
  number = {1},
  pages = {43--46},
  doi = {10.1093/mrcr/rxac018}
}
Kostenlos starten →